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Abstract
Background: The non-destructive assessment and characterization of tridimensional (3D) cell and tissue constructs
in bioreactors represents a challenge in tissue engineering. Medical imaging modalities, which can provide
information on the structure and function of internal organs and tissues in living organisms, have the potential of
allowing repetitive monitoring of these 3D cultures in vitro. Positron emission tomography (PET) is the most
sensitive non-invasive imaging modality, capable of measuring picomolar amounts of radiolabeled molecules.
However, since PET imaging protocols have been designed almost exclusively for in vivo investigations, suitable
methods must be devised to enable imaging of cells or tissue substitutes. As a prior step to imaging 3D cultures,
cell radiotracer uptake conditions must first be optimized.
Methods: In this study, human umbilical vein endothelial cells (HUVEC) and human fibroblasts were cultured at
different densities and PET was used to non-destructively monitor their glycolytic activity by measuring
18F-
fluorodeoxyglucose (
18FDG) uptake. Various cell preconditioning protocols were investigated by adjusting the
following parameters to optimize
18FDG uptake: glucose starvation, insulin stimulation, glucose concentration,
18FDG incubation time, cell density and radiotracer efflux prevention.
Results: The conditions yielding optimal
18FDG uptake, and hence best detection sensitivity by PET, were as
follows: 2-hour cell preconditioning by glucose deprivation with 1-hour insulin stimulation, followed by 1-hour
18FDG incubation and 15-minute stabilization in standard culture medium, prior to rinsing and PET scanning.
Conclusions: A step-wise dependence of
18FDG uptake on glucose concentration was found, but a linear
correlation between PET signal and cell density was observed. Detection thresholds of 36 ± 7 and 21 ± 4 cells
were estimated for endothelial cells and fibroblasts, respectively.
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Introduction
The growth of tissue substitutes is a dynamic process,
requiring close monitoring of cell viability and function
over time. Unfortunately, most of the commonly available
cell assays (e.g., histology, immunofluorescence or immu-
nocytochemistry) are time consuming and require
sacrificing the culture. Although these techniques provide
important information on cell phenotype and function,
they are often only representatives of specific time points
and selected samples within the culture. It remains diffi-
cult to trace the evolution of the cell or tissue cultures
over time. Our inability to obtain continuous direct infor-
mation on culture conditions and cells state in thick (few
mm to cm range) 3D culture chambers represents a major
weakness in understanding bioreactors performance. The
main challenge nowadays is to find suitable real-time,
non-invasive and, most importantly, non-destructive
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transparent cell and tissue cultures. As reviewed by Dubois
et al. [1], imaging techniques borrowed and adapted from
the biomedical field can be used to monitor the dynamic
tissue growth process without interference. While imaging
modalities such as X-ray computed tomography (CT) and
magnetic resonance imaging (MRI) can provide subtle
morphological details, functional imaging using picomolar
amounts of radiolabeled molecules can be used to obtain
sensitive information on the underlying biological and bio-
chemical processes non-destructively. Positron Emission
Tomography (PET), in particular, offers great potential to
monitor cell metabolism, proliferation, angiogenesis, per-
fusion, hypoxia or apoptosis using a range of specific
radiotracers without hindering normal tissue development.
[
18F]-fluorodeoxyglucose (
18FDG), a glucose analog labeled
with the positron-emitting radioisotope fluorine-18 that
can be used as a cell glycolysis marker, is the most com-
monly used PET tracer.
18FDG uptake can provide valu-
able information on cell viability, proliferation and initial
tissue perfusion in bioreactors [2-4]. In humans, vascular
18FDG uptake is usually undetectable except in some cases
of vasculitis or atherosclerosis [5]. Knowing the impor-
t a n c eo fm i c r o v a s c u l a t u r ei nt i s s u ee n g i n e e r i n g ,w e
focussed our efforts on increasing
18FDG uptake by fibro-
blasts and endothelial cells [6]. To improve the PET signal
from the target tissue, a proper imaging protocol had to
be devised and the uptake parameters of the radiotracer
by cells in the culture optimized. As the tissue culture in
bioreactors is dependent on several environmental para-
meters, a screening method to assess the best radiotracer
uptake conditions for cell types of interest was first
developed.
This study describes a fast in vitro screening method
allowing many parameters with potential impact on cell
18FDG uptake to be evaluated concurrently. A 2-step
method was designed to quantitatively measure the
radiotracer PET signal by imaging living cell monolayers
under various culture conditions, allowing the cell
18FDG
uptake parameters to be optimized. The proposed steps
are 1) a factorial design and 2) a detailed screening for
each major acting parameter found in step 1.
Materials and methods
Human umbilical vein endothelial cells (HUVEC, C-
12203) and human dermal fibroblasts (C-12350) were pur-
chased from PromoCell (Heidelberg, Germany). Fetal
bovine serum (FBS, F-1051), Medium 199 (M199, M5017),
endothelial cell growth supplement (ECGS, E2759),
heparin (H1027), gelatin type B (G9391) and Hoechst
33342 (14533) were all obtained from Sigma-Aldrich
(Oakville, ON, Canada). Phosphate Buffered Saline
(BP665-1), and disposable plastic wares came from Fisher
Scientific (Whitby, ON, Canada). Trypsin-EDTA (25200-
056) and antibiotics (penicillin G/streptomycin sulphate
(15140-122)) were obtained from Invitrogen (Burlington,
ON, Canada). 5% dextrose water solution (JB0062) came
from Baxter (Mississauga, ON, Canada), glucose-free
DMEM (319-061-CL) from Wisent (St-Bruno, QC,
Canada) and human Novolin Toronto insulin (DIN
02024233) from Novo Nordisk (Mississauga, ON, Canada).
Nunc’s Lab-Tek II 8 chamber slides (62407-296) were pur-
chased from VWR (Mississauga, ON, Canada).
Cell culture
HUVEC and fibroblasts were cultured in M199 supple-
mented with 10% FBS, heparin (90 μg/mL), L-glutamine
(2 mM), penicillin G (50 U/mL) and streptomycin sul-
phate (50 μg/mL). ECGS (20 μg/mL) was added to
HUVEC culture media. Cells were kept in an incubator
(5% CO2 in humid atmosphere). HUVEC at passage 3 or 4
were used to avoid senescence [7]. Cell seeding was always
performed on surfaces coated with gelatin (gelatin solution
concentration of 100 μg/mL) to promote cell adhesion and
limit batch-to-batch variation towards cell attachment.
Radiochemistry
Fluorine-18 was prepared by the
18O(p, n)
18F reaction
on
18O enriched water as target material using a TR-19
cyclotron (Advanced Cyclotron Systems, Vancouver, BC,
Canada). For the synthesis of [
18F]fluorodeoxyglucose
(
18FDG), an established procedure was used [8].
Step 1 - Factorial design to identify variables affecting
18FDG uptake by cells
To optimize cell signals for PET detection, a factorial
design was employed to study the effects of variables
among
18FDG incubation time, cell density, insulin expo-
sure and concentration, glucose concentration and cul-
ture stabilization time on
18FDG uptake by cell
monolayers. A non-replicated one block 2 k-2 factorial
design with 3 center points was used for the
18FDG cell
uptake experiments. This method in conjunction with
ANOVA is well adapted for the identification of the con-
ditions having the most impact on cell uptake of
18FDG.
Upper and lower thresholds were defined for each vari-
able investigated in this study, based on our personal
experience and the limitations imposed by
18FDG half-
life. The variables studied and their corresponding
thresholds are presented in Table 1 and parameters were
classified in order of influence. The selected limits com-
bined with the factorial design of experiments including
center points and 2 rinsing controls yielded a total of 16
experiments. Design of experiments and statistical ana-
lyses of the results were doneu s i n gt h eS t a t - E a s es o f t -
ware (Stat-Ease Inc., Minneapolis, MN), using ANOVA.
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tistically significant. The experimental steps and the fol-
lowed order are presented in Figure 1.
Step 2 - Cell preconditioning to increase
18FDG uptake
In light of the factorial design results, a new experimen-
tal design and timelime was determined. The new pro-
tocol is summarized in Figure 2. The starvation period
was shortened to 2 hours and the 1-hour
18FDG incuba-
tion was preferred since the gain for the extra hour was
not deemed sufficient considering the loss caused by the
109.8 minutes half-life of the
18 F radiotracer. The used
insulin concentration was also lowered down to a phy-
siological level. The most important parameter affecting
cell
18FDG uptake (glucose starvation) was further inves-
tigated to find which optimal glucose concentration
should be used without affecting the samples. Once
found, the influence of cell density on the measured sig-
nal was tested.
Samples preparation
After seeding, cells were given 8 hours to adhere and
spread in the chamber slides (Figure 3A). This period
was enough to avoid energetic demand caused by the
cell attachment procedure and short enough to prevent
density variation due to proliferation before starting any
treatment.
Starvation
Glucose starvation media consisted in glucose-free
DMEM with 1% FBS supplemented with a 5% dextrose
solution to set the desired glucose concentrations (0 to 7
mM). Each well was rinsed thrice with starvation media
and left to incubate at 37°C with 5% CO2 under humid
atmosphere. The incubation media volume represented
20% of the overall volume capacity of the well. Since this
parameter could deeply affect cells, we tested the effect
of glucose starvation on cell morphology and cell number
to validate a safe working range. Cells were incubated for
2 hours in supplemented DMEM with different glucose
concentrations (n ≥ 3) ranging from 0 to 7.0 mM with
increments of 0.5 mM. Cell morphology was assessed
before and after each glucose starvation treatment. To
count cells, samples were incubated 30 min in 1/1000
Hoechst 33342 and were then scanned with an iCys ima-
ging cytometer (Compucyte, Westwood, MA) using a
violet diode excitation laser (405 nm) with blue detector
(465/20 nm) for DNA staining and scatter detector for
visualization of cytoplasm. Scanning was performed at a
1 μm×0 . 5μm pixel size resolution. Cell selection was
done using DNA staining taking into account cell DNA
content, allowing to score correctly for cell clumps and
to reject small fragments containing DNA.
Insulin
A1 0
-8 M physiological insulin concentration was added
to every well 1 hour after treatment onset and 1 hour
before
18FDG injection since its effects take 30-45 min-
utes to occur before lasting a few hours. 1 mole of insulin
corresponds to 166.8 × 10
6 IU or 1.0 IU = 6.0 nmol [9].
18FDG incubation
1 hour post-insulin, the radiotracer was supplemented in
excess using 2-3 MBq (15 μL) of
18FDG in every well.
Stabilization
After a 1-hour incubation with
18FDG, the wells were
filled up to 50% of their volume capacity using M199
Table 1 Thresholds of the experimental design for all cell types in order of influence
Variables Lower threshold Upper threshold
18FDG uptake gain P-value
Starvation time 0 h 3 h 43.9% < 0.0001*
Cell density 10 000 cells/mL 50 000 cells/mL 20.3% 0.0002*
18FDG incubation time 1 h 2 h 5.8% 0.0062*
Insulin concentration 0.0 nmol/mL 6.0 nmol/mL 1.4% 0.1016
Insulin incubation time 0 h 1 h 1.0% 0.1475
* P-values of less than 0.05 indicate model parameters are significant
Cellseeding
Starvation
Insulin
18FDGincubation
Stabilization
Rinsing
PETscan
Figure 1 Experimental timeline for the factorial design.
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15 to 60 minutes to evaluate the
18FDG efflux.
Rinsing
After stabilization, wells were all carefully rinsed 4 times
with the corresponding fresh starvation solution to
remove free
18FDG and the fourth rinse was counted to
check for the presence of residual radioactivity before
scanning. Every last rinse had to be
18FDG-free to ascer-
tain that the PET signal only originated from cell uptake.
Each chamber slide also had one cell-free well that was
treated like the others (
18FDG and rinses) and served as a
background reference.
Cell culture imaging
Positron emission tomography (PET) imaging was used
to monitor the cell
18FDG uptake together with X-ray
computed tomography (CT) imaging to define the mor-
phology of the chamber slides. A Triumph™ PET/CT
Figure 2 Experimental timeline for step 2.
Figure 3 A) Cells seeded in chamber slides, B) Stacked chamber slides for PET scanning, C) Aligning stack in PET axial and trans-axial
field of view (FOV), D) CT images used to draw regions of interest (ROI), E) PET image with an example of projected CT-defined ROI
for PET data analysis.
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Northridge, CA, USA) was used, which consisted of a
LabPET™ avalanche photodiode-based digital PET scan-
ner with a 7.5 cm axial field-of-view [10] capable of
achieving a transaxial spatial resolution of 1.2 mm and a
detection efficiency of 2.1% with an energy window set-
ting of 250-650 keV.
Chamber slides were mounted in stacks (Figure 3B)
and centered in the scanner transaxial and axial field of
view (FOV) (Figure 3C). One-hour static PET data acqui-
sitions with axial double sampling motion to improve
resolution were performed for every cell imaging session,
f o l l o w e db y5 - m i n u t es t a t i ci m a g i n go fap h a n t o mc o n -
taining a known amount of
18FDG at the end of the ima-
ging period to allow for the conversion of detected events
(in CPS/Pixel) into MBq of retained activity in cells. The
calibration phantom consisted of cell-free chamber slides
with two known
18FDG concentrations in volumes of
200 μL pipetted in non-consecutive chambers. The scan-
ner efficiency was further normalized within a day of the
measurement with a
68Ge 18.5 MBq rotating line source
(PET-78/0.5, Sanders Medical, Knoxville, TN) for at least
4.5 hours to ensure reproducibility between measure-
ments, which were taken up to several weeks apart. PET
images were reconstructed on a 0.25 mm × 0.25 mm ×
1.1175 mm grid using 20 iterations of a 2D maximum-
likelihood expectation maximization (MLEM) algorithm
implementing position-dependent detector response [11].
Corrections for individual detector efficiency and random
coincidences were applied, but attenuation and scatter
corrections were omitted since they were unnecessary
given that all measurements were taken with the same
stacked thin chamber slides geometry. CT acquisition
was performed in fly mode with 512 projections in
2.13 min at 60 KVP and 220 μA .T h es i n g l ef r a m ew a s
reconstructed in 0.17 × 0.17 × 0.17 mm
3 voxels.
The Amide freeware (sourceforge.net version 0.9.2) was
used to analyze the radiotracer concentration in the
reconstructed images, using the CT scan image of the
culture slide to draw 8 equal regions of interest (ROI)
over each chamber (Figure 3D). These ROI were then
projected on the corresponding PET images for data ana-
lysis (Figure 3E).
Results
Factorial design
The results of the factorial design experiments are sum-
marized in Table 1. Design showed that all, but insulin
concentration and incubation time had a P-value < 0.05.
The 3-hour glucose starvation period before exposing
cells to
18FDG was the most significant factor, which
alone represented 44% of the total radiotracer uptake
enhancement. Cell density was the second most impor-
tant factor with a 20% impact.
Different stabilization periods were evaluated to facili-
tate cell
18FDG trapping and avoid efflux. These pro-
cesses are dependent on cell hexokinase activity [12],
the rate-determining step for metabolic trapping [13,14]
and
18FDG-6-phosphate dephosphorylation by glucose
6-phosphatase [15,16]. Indeed, hexokinase had been
shown to reach a maximum activity starting at 5 mM of
glucose and over [17]. To maximise
18FDG confining
and minimise efflux, once the radiotracer incubation
time was elapsed, we added 5.5 mM glucose containing
10% FBS to each well for periods of 0, 15, 30 or 45 min-
utes before rinsing. We found that a stabilization time
between 15 to 30 minutes gave a stable signal and this
period was considered optimal for both cell types.
Effect of glucose starvation on cell morphology
When using PBS as a glucose-free buffer at 37°C, all
cells, especially HUVEC, became spherical and detached
from the surface, which is consistent with previous
observations [18]. A treatment that changes samples
morphology would not be appropriate for bioreactor
cultures. This problem was solved using glucose-free
DMEM instead. Fibroblasts did not undergo morpholo-
gical changes under any conditions with this starvation
medium (n = 3) (Figure 4A). HUVEC (Figure 4B), on
the other hand, showed morphological changes with
glucose concentration lower than 1.5 mM (Figure 4C)
and were completely round after 2 hours in 0.5 mM
(Figure 4D). Most cells shown in Figure 4D did not
recover from glucose starvation after 48 hours in com-
mercial 5.5 mM glucose containing M199.
Effect of glucose starvation on
18FDG uptake
HUVEC and fibroblast monolayers were each treated
with media containing different glucose concentrations
and subsequently scanned by PET to assess their
18
FDG uptake, as shown in Figure 5a, b, and 5c. A pla-
teau was observed in scans of fibroblasts between 2.5
and 4.0 mM of glucose (Figure 5d), so further investi-
gation were carried out in that range to confirm these
observations. Quantitative PET data obtained by ROI
analysis, after correction for radioactive decay, are
reported in Figure 6A. For fibroblast monolayers,
18FDG signal decreases steeply in a linear fashion (R
2 =
0.9972) from 0.5 to 2 mM of glucose, then slightly
rebounds to a plateau between 2.5 and 4 mM, to fall
again most probably because the glucose concentration
exceeded cell needs and entered in competition with
18FDG. For HUVEC, excluding the result for 0.5 mM
glucose treatment that deeply affected cell morphology
(Figure 6A, star), the
18FDG signal drops steeply
between 1.0 and 1.5 mM, then levels off between 1.5
and 3 mM, before steadily decreasing for higher glu-
cose concentrations.
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A linear correlation was found between
18FDG signal
and the number of cells. Assuming that a signal-to-
noise ratio equal or larger than 3 is significant, detection
thresholds of 36 ± 7 cells for HUVEC and 21 ± 4 cells
for fibroblasts were extrapolated from the linear correla-
tions used to fit data in Figure 6B. The difference of
slope between HUVEC and fibroblasts in this experi-
ment reflects the higher
18FDG uptake by the latter, in
agreement with results obtained in Figure 6A.
Discussion
Glucose deprivation is known to gradually increase total
cellular transporter proteins [19,20] and is also associated
with decreased protein turnover in mammalian fibro-
blasts [19]. Starved mammalian cells under low glucose
concentration conditions undergo a p53 dependent G1
phase arrest that is quickly reversible upon glucose
restoration [21]. Fibroblasts have been showed to have a
24-hour survival capacity starting from 0.1 mM of glu-
cose [21], which is in agreement with our results. Highest
18FDG uptakes were always obtained under a 2 mM glu-
cose concentration, but such a low glucose concentration
affected HUVEC morphology (Figure 4C-D). The spher-
oid HUVEC appearance observed under 1.5 mM glucose
concentration can be due to cell-cell detachment caused
by F-actin conversion in G-actin rather than being a con-
sequence of cell death induction [22]. However, not every
preconditioning treatment susceptible to influence cell
morphology can be considered f o ri m a g i n gc e l lo rt i s s u e
substitutes.
When working with HUVEC, the optimal
18FDG uptake,
while still maintaining cell integrity, was achieved using 3
mM glucose containing DMEM. The 3 mM glucose con-
centration also corresponded to the uptake plateau for
fibroblasts. Hence, this glucose concentration was used for
the cell density gradient experiments shown in Figure 5e
and 5f and analysed in Figure 6B. Nearly all cell culture
media contain a glucose concentration of at least 5.5 mM,
which can be considered as a tremendous source of carbo-
hydrate able to last for days [23]. Most cells do not need
that much glucose and quickly become saturated, making
them produce and excrete lactate [23]. Lowering the glu-
cose level to 3 mM for 2 hours increased
18FDG uptake to
approximately twice that found when using 5.5 mM media
for both HUVEC and fibroblasts. Endothelial cells were
Figure 4 Laser scanning cytometry images of fibroblasts (A) and HUVEC incubated 2 hours in DMEM containing 2, 0.5 and 0 mM
glucose (B to D respectively). A is representative of all fibroblast samples. B is representative of all glucose concentrations above 2 mM.
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responsiveness according to their organ of origin, so cau-
tion should be exercised when applying these results to
other cell types [24].
The FBS supplemented M199 medium used for the cell
culture contained 4 mM glucose, but since it was used at a
concentration of 1% in the cell starvation media, this
amount of added glucose was considered as non signifi-
cant. Hiraki et al. [25] reported that glucose transport is
also regulated by calf serum growth factors in a concentra-
tion-dependent manner. Considering that serum induced
a first rise of sugar uptake within 10 minutes and a second
at approximately 1 hour due to the activation of glucose
transporter gene expression [25], it might be possible to
gain extra signal by using 15% FBS containing DMEM
before adjusting the glucose level to 3 mM.
Over-expression of insulin-receptors in HUVEC
showed the presence of a functional insulin pathway
Figure 5
18FDG/PET images of HUVEC (H) and fibroblasts (F) pretreated with media containing glucose concentrations from 0.5 to 7.0
mM (a to c). Panel (d) shows a closer look at the plateau found with fibroblasts between glucose concentrations of 1.5 and 4.5 mM. Note that
the color scale has been stretched in (d) to better appreciate the subtle differences between relatively similar samples. Numbers above and
below the PET images represent the media glucose concentration in mM. Panels e and f show PET images of fibroblast and HUVEC monolayers
at different cell densities treated with 3 mM glucose. Numbers above and below these images indicate the numbers of cells at seeding (8 hours
prior to scanning).
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18FDG signal had been noticed
in our data when using 10
-8 Mi n s u l i n ,b u tt h i se f f e c t
turned out not to be statistically significant. Insulin
action might not be a major actor in our system, but
anything that could bring some improvement is always
welcome, so a 10
-8 M physiological concentration was
preserved in our protocol, as suggested by the maximum
insulin effect observed by Gerritsen et al. [13,27]. It
must also be kept in mind for further studies that tis-
sues such as heart, skeletal muscles and adipose tissues
do present the insulin responsive glucose transporter
GLUT4 [28-30], so even if our results with fibroblasts
(known to have GLUT1, 3 and 4 [31]) turned out not to
be significant, we strongly suggest that the insulin para-
meter always be tested.
Now that a protocol to maximize
18FDG cell uptake
has been established, further studies are being planned
to investigate additional parameters that are known to
influence glucose uptake in cells, such as the presence
of nitric oxide [12,24,26], growth factors [32], hypoxia
[33], and proliferation.
More imaging studies will be needed to fully under-
stand the importance of these factors in high cell density
cultures, and PET imaging offers considerable potential
to achieve this goal. Numerous key parameters must be
dynamically monitored in real time in tissue cultures to
optimize their development, which include morphology,
viability, proliferation, metabolism, angiogenesis, perfu-
sion, nutrient and oxygen consumption, hypoxia, apopto-
sis, and sometimes secretion of specific proteins. So far,
only
18FDG, a cell glycolytic activity marker, has been
investigated, but several other PET tracers are available,
such as
18F-f l u o r o t h y m i d i n e(
18FLT) and
11 C-methio-
nine to, respectively, monitor DNA and protein synthesis,
18 F-fluoromisonidazole (
18 F-MISO) for imaging hypoxia
[34], and
18F- or
64Cu-labeled annexin-V for measure-
ment of apoptosis [35,36]. It would also be possible to
adapt the proposed protocol for non-adherent (floating)
cells by using microtubes for imaging instead of the
square culture chambers. A centrifugation step would
then be required prior to media removal for rinsing.
Since radiotracers can sometimes bind to the microtube’s
wall, it may be advisable to transfer the suspension in a
fresh tube after every rinse to avoid contamination from
the container in the PET images.
Extension of the protocol used in this study to other
cell types would be straightforward, provided that they
have a similar growth rate and
18FDG delivery times. Due
to the 109.8 minutes half-life of fluorine-18, the used
experimental set-up with
18FDG could hardly be feasible
under longer working conditions than the 12-h protocol
used here. Obviously, other biological parameters could
be monitored over extended observation periods with
possibly longer incubation times using molecular probes
labelled with longer half-life radiotracers, such as
64Cu
(12.8 h),
89Zr (78 h) or
124I (4.18 d).
Conclusions
In this study, we have investigated the
18FDG uptake of
two human cell types of importance in many tissue
engineering applications. Parameters influencing
18FDG
uptake by HUVEC and human fibroblasts have been
optimized by directly imaging living cell monolayers
with PET using a fast screening in vitro method. Results
show that glucose starvation combined with insulin
A
B
Figure 6 Quantitative PET data analysis (n ≥ 3) as a function of
glucose concentration during the 2-hour starvation (A) and cell
density at seeding (B). The star in (A) indicates that cell
morphology was deeply affected (see Figure 4C).
Chouinard et al. Vascular Cell 2012, 4:5
http://www.vascularcell.com/content/4/1/5
Page 8 of 10stimulation greatly enhanced
18FDG PET signal from
HUVEC and fibroblast monolayers. For optimum signal,
we recommend a 2-hour starvation period in 3 mM glu-
cose and 1% FBS containing DMEM, followed by a 1-
hour
18FDG incubation (two hours did show more
uptake, but the gain was not enough to compensate for
the loss of signal due to
18 F radioactive decay). These
conditions improve the
18FDG PET signal without hav-
ing detrimental effects on cell homeostasis and survival.
Following such preconditioning treatment, a 15-30 min-
ute stabilization period, where commercially available
5.5 mM culture medium containing 10% FBS is added
to the incubation medium, is also advised to reduce
18FDG cell efflux. Using this method, detection thresh-
olds of 36 ± 7 and 21 ± 4 cells were achievable for
HUVEC and fibroblasts, respectively. Future plans
include the validation of the optimized parameters in a
more realistic 3D in vitro model. This study provides
support to further develop and validate non-invasive
and non-destructive imaging methods such as PET to
monitor and characterize high cell density cultures in
tissue engineering. Moreover, the data collected in this
in vitro imaging experiment of vascular cells could be
helpful in devising clinically relevant imaging protocols
for studying various vascular diseases.
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